Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
NCT04083482 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2019-09-10
Summary
The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation（CVVH）
Conditions
- Intensive Care Unit
Interventions
- PROCEDURE
-
continous venovenous hemofiltraion
CVVH
Sponsors & Collaborators
-
First People's Hospital of Chenzhou
lead OTHER
Principal Investigators
-
dixian luo, MS · Chenzhou First people Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2018-09-20
- Completion
- 2019-12-31
Countries
- China
Study Locations
More Related Trials
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
NCT00541827 ·Status: COMPLETED
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
NCT04970602 ·Status: UNKNOWN ·Phase: NA
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
Resuscitation Failure, Oxidative Stress, and Necroptosis as Mortality Predictor in Septic Patient
NCT04169412 ·Status: COMPLETED
-
Homocysteine in Patients With Sepsis
NCT04548414 ·Status: UNKNOWN
-
The Efficacy of Xuebijing Injection on Sepsis
NCT03238742 ·Status: COMPLETED ·Phase: PHASE4
-
Fluid Responseveness in Sepsis and Its Correlation to CVP
NCT05612529 ·Status: TERMINATED
-
Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis
NCT04480632 ·Status: UNKNOWN ·Phase: PHASE2
-
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of ECMO Use and Conventional Treatment in Adults With Septic Shock
NCT01685112 ·Status: UNKNOWN
-
Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma
NCT04468009 ·Status: COMPLETED ·Phase: PHASE2
-
Early Lactate Clearance Rate in Sepsis
NCT04192279 ·Status: UNKNOWN
-
Removal Peripheral Intravenous Catheters According to Clinical Signs or Every 96 Hours: A Non Inferiority Study
NCT02568670 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis
NCT04057872 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of Sepsis
NCT01501097 ·Status: UNKNOWN ·Phase: NA
-
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
NCT06220929 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
NCT01484106 ·Status: COMPLETED ·Phase: NA
-
Effect of Different Strategies for Titrating a High MAP on Microcirculation
NCT02085291 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of PCR-CRISPR/Cas12a on the Early Anti-infective Schemes in Patients With Open Air Pneumonia
NCT04178382 ·Status: UNKNOWN ·Phase: NA
-
Thromboelastometry in Assessment of Sepsis Coagulopathy
NCT02971111 ·Status: COMPLETED